Ketamine and Monoamine Oxidase Inhibitor Combination: Utility, Safety, Efficacy?

J Clin Psychopharmacol. 2020 Nov/Dec;40(6):636-638. doi: 10.1097/JCP.0000000000001281.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Affect / drug effects*
  • Antidepressive Agents / administration & dosage*
  • Antidepressive Agents / adverse effects
  • Depressive Disorder, Treatment-Resistant / diagnosis
  • Depressive Disorder, Treatment-Resistant / drug therapy*
  • Depressive Disorder, Treatment-Resistant / psychology
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Humans
  • Infusions, Intravenous
  • Ketamine / administration & dosage*
  • Ketamine / adverse effects
  • Middle Aged
  • Monoamine Oxidase Inhibitors / adverse effects
  • Monoamine Oxidase Inhibitors / therapeutic use*
  • Remission Induction
  • Treatment Outcome
  • Young Adult

Substances

  • Antidepressive Agents
  • Monoamine Oxidase Inhibitors
  • Ketamine